Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > AMCo's #1 Drug
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by yycish1027on Jul 09, 2016 10:40pm
183 Views
Post# 25038784

RE:RE:RE:RE:RE:RE:AMCo's #1 Drug

RE:RE:RE:RE:RE:RE:AMCo's #1 DrugAt the end of the John's cxr market call, Cathy suggested the caller to review yesterday's market call as previous hedge fund manager was shorting this. This is where she said it was better to listen both side.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities